18 October 2018
Free mini cosmetic surgery consultation evening with Mr Grant
We welcome your views on our website and invite you to take part in a brief survey when you've finished your visit.
Your response will help us improve the site and the experience we offer to visitors.
Some of the principal treatments carried out by Mr Philip Alexander at Spire include:
Mr Alexander is a Consultant Ophthalmologist with particular expertise in cataract and vitreoretinal surgery.
Mr Alexander graduated from the University of London in 2002 with Distinction and a number of academic prizes. He gained comprehensive training in all aspects of Ophthalmology, and has completed advanced subspecialist surgical training in Nottingham, Southampton and at Moorfields Eye Hospital, London. He is currently a Consultant Ophthalmic and Vitreoretinal Surgeon at Cambridge University Hospitals, and is part of the team running the Stickler Syndrome Diagnostic Service commissioned by NHS England.
He has over 45 publications in the scientific literature, and in 2013 was awarded funding from the Global Ophthalmology Awards Programme (GOAP) to conduct research into ocular stem cell transplantation, for which he later received a doctorate. He has presented his work at national and international meetings, and at the Houses of Parliament.
Mr Alexander trains Ophthalmologists on the East of England Specialist Training Programme, and trains Vitreoretinal Surgical Fellows at Addenbrooke’s Hospital.
Mr Alexander’s MBA thesis focussed on healthcare innovation for patients with diabetic eye disease.
In 2016, Mr Alexander was invited to attend the Ophthalmology Honours ceremony at the Royal College of Surgeons, where the Stickler Syndrome Service at Cambridge University Hospitals was given the Judge’s Special Award in recognition of the “highly specialised” and “world class” service that it delivers.
MBBS (Distinction) / University of London / 2002
Bachelor of Medicine, Bachelor of Surgery
MBBS is the degree given to physicians when they qualify as a doctor
Fellow of the Royal College of Ophthalmologists
Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation TrustBack to top
Co-Founder and CEO of VisusNano Ltd, a privately held pre-clinical company developing a drug-eluting intraocular lens implant, for use in patients undergoing cataract surgery. This novel medical device will improve patient outcomes, and eliminate the need for eye drops after surgery. VisusNano Ltd has won several awards, including Oxford Biostars 2016.Back to top